Syncope-Asystole Latency Time in Tilt Table Test: The SALT-TILT Study

计划入组 64 人 · 首次发布于 2024 年 4 月 10 日

Pelvic Tilt Following Puerperium

计划入组 42 人 · 首次发布于 2023 年 8 月 31 日

TNFalpha and Interleukin 2 Coding Oncolytic Adenovirus TILT-123 During TIL Treatment of Advanced Melanoma

计划入组 17 人 · 首次发布于 2020 年 1 月 3 日

TILT-234

TILT-321

TILT-322

TILT Biotherapeutics Oy

Finland

Biglari Holdings

United States

BrightView Holdings

United States

TILT Biotherapeutics Presents Promising Clinical Data on Intravenous TILT-123 at ESMO 2024

Curaleaf International Secures EU Medical Device Certification for Pioneering Cannabis Inhalation Technology

TILT Biotherapeutics Advances TILT-123 Immunotherapy with Positive Clinical Trial Data